These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The burden of Clostridium difficile in surgical patients in the United States. Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114 [Abstract] [Full Text] [Related]
26. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections. Mac Aogáin M, Moloney G, Kilkenny S, Kelleher M, Kelleghan M, Boyle B, Rogers TR. J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700 [Abstract] [Full Text] [Related]
27. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers. Pakyz A, Carroll NV, Harpe SE, Oinonen M, Polk RE. Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438 [Abstract] [Full Text] [Related]
28. Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults. Chen Y, Glass K, Liu B, Korda RJ, Riley TV, Kirk MD. Am J Infect Control; 2017 May 01; 45(5):508-511. PubMed ID: 28089675 [Abstract] [Full Text] [Related]
29. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Webb BJ, Brunner A, Ford CD, Gazdik MA, Petersen FB, Hoda D. Transpl Infect Dis; 2016 Aug 01; 18(4):628-33. PubMed ID: 27214585 [Abstract] [Full Text] [Related]
36. Healthcare resource utilization and direct medical costs associated with index and recurrent Clostridioides difficile infection: a real-world data analysis. Feuerstadt P, Stong L, Dahdal DN, Sacks N, Lang K, Nelson WW. J Med Econ; 2020 Jun 01; 23(6):603-609. PubMed ID: 31999199 [Abstract] [Full Text] [Related]